Locoregional and Overall Recurrence After Neaodjuvant Endocrine Therapy Versus Chemotherapy in Postmenopausal Women With Estrogen Receptor+ HER2− Breast CancerJean L. Wright, Judith Hurley, Cristiane Takita et al.|American Journal of Clinical Oncology|2015Cited by 11
Neoadjuvant chemotherapy versus neoadjuvant hormonal therapy in postmenopausal women with ER-positive, HER2/neu negative locally advanced breast cancer.Tadeu Ambros, Judith Hurley, Isildinha M. Reis et al.|Journal of Clinical Oncology|2012Cited by 1